ANAB – anaptysbio, inc. (US:NASDAQ)
Stock Stats
News
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $66.00 to $36.00. They now have an "overweight" rating on the stock.
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Truist Financial Co. from $30.00 to $20.00. They now have a "hold" rating on the stock.
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
AnaptysBio Stock Down as Eczema Study Fails to Meet Goals [Yahoo! Finance]
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Guggenheim from $90.00 to $36.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G ANAPTYSBIO, INC Filed by: Fairmount Funds Management LLC
Form 8-K ANAPTYSBIO, INC For: Dec 11
Form 4 ANAPTYSBIO, INC For: Nov 29 Filed by: RENTON HOLLINGS
Form 144 ANAPTYSBIO, INC Filed by: RENTON HOLLINGS
Form EFFECT ANAPTYSBIO, INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.